AtriCure Reports First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500, Dow futures attempt recovery ahead of inflation report
- Oracle raises full year profit guidance, stock rises after hours
- Oil surges 6%, Brent and US crude both surpass $100 on more tanker attacks
- Analysts split on Apple after foldable iPhone Duo debut
- JPMorgan upgrades Meta on AI models and agents, sees 'meaningful headroom'
- White House copper tariff plan stalls amid affordability concerns, sources say
- Micron's Taiwan workers to get rewards worth up to 68 months of pay
- Crude Inventory 0.4M Barrels Last Week - EIA
- Vertiv shares drop on acquisition skepticism, AI pullback
- S&P 500, Dow futures attempt recovery ahead of inflation report
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
AtriCure Inc. (ATRC) PT Raised to $81 at Needham & Company
April 28, 2021 6:20 AM EDTNeedham & Company analyst Mike Matson raised the price target on AtriCure Inc. (NASDAQ: ATRC) to $81.00 (from $74.00) while maintaining a Buy rating.
The analyst commented, "ATRC's 1Q21 revenue, adjusted EBITDA, and adjusted EPS all beat consensus. The impact from the pandemic eased during the... More
AtriCure (ATRC) Tops Q1 EPS by 5c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus
April 27, 2021 4:06 PM EDTAtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.32), $0.05 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $59.3 million versus the consensus estimate of $56.06 million.
Our growth in the first quarter is a testament of our teams strong execution and unwavering dedication... More
